a-Ergocryptinine - contains up to 10% ethyl acetate
CAS: 511-10-4
Ref. 3D-FE22783
| 1mg | A consultar | ||
| 2mg | A consultar |
Información del producto
- ErgokryptinineIsoergokryptinea-Ergocryptinine
- (5Alpha,5'Beta)-12'-Hydroxy-5'-(2-Methylpropyl)-3',6',18-Trioxo-2'-(Propan-2-Yl)Ergotaman
- (5′α,8α)-12′-Hydroxy-2′-(1-methylethyl)-5′-(2-methylpropyl)ergotaman-3′,6′,18-trione
- (8alpha)-12'-Hydroxy-5'alpha-isobutyl-2'-isopropylergotaman-3',6',18-trione
- 8H-Oxazolo[3,2-a]pyrrolo[2,1-c]pyrazine, ergotaman-3′,6′,18-trione deriv.
- Ergocryptinine
- Ergokryptinine
- Ergotaman-3',6',18-trione, 12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5'alpha,8alpha)-
- Ergotaman-3′,6′,18-trione, 12′-hydroxy-2′-(1-methylethyl)-5′-(2-methylpropyl)-, (5′α,8α)-
- Indolo[4,3-fg]quinoline, ergotaman-3′,6′,18-trione deriv.
- Ver más sinónimos
- Isoergokryptine
- α-Ergocryptinine
- α-Ergokryptinine
Ergocryptine is a drug that is used in the treatment of inflammatory diseases. It is an analog of ergocryptine and contains up to 10% ethyl acetate. Ergocryptine inhibits the production of various cytokines, such as tumor necrosis factor-α (TNF-α), and reduces the infiltration of inflammatory cells into tissues. This drug has been shown to reduce restenosis rates in animal studies. Ergocryptine has also been shown to inhibit matrix metalloproteinases (MMP) activity and expression, which may contribute to its anti-inflammatory effects.
Propiedades químicas
Consulta técnica sobre: 3D-FE22783 a-Ergocryptinine - contains up to 10% ethyl acetate
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
